This is a demo store. No orders will be fulfilled.

Teclistamab (anti-CD3&BCMA), T 细胞表面糖蛋白的结合剂 CD3 结合剂

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human)
  • 亚型: Human IgG4SP
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab175669-100μg
100μg 现货 Stock Image
Ab175669-1mg
1mg 现货 Stock Image
Ab175669-5mg
5mg 现货 Stock Image
Ab175669-10mg
10mg 期货 Stock Image

基本信息

产品名称 Teclistamab (anti-CD3&BCMA), T 细胞表面糖蛋白的结合剂 CD3 结合剂
别名 特立妥单抗 | CD3抗体 | CD3药靶抗体 | BCMA抗体 | BCMA药靶抗体 | CD3E抗体 | CD3E药靶抗体 | TNFRSF17抗体 | TNFRSF17药靶抗体
英文别名 CD3 epsilon antibody | CD3e antibody | CD3e antigen antibody | CD3e antigen epsilon polypeptide (TiT3 complex) antibody | CD3E antigen epsilon polypeptide antibody | CD3E antigen, epsilon subunit antibody | CD3e molecule epsilon antibody | CD3e molecule,
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA
生化机理 CD3: The CD3 complex mediates signal transduction. BCMA: Receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. Promotes B-cell survival and plays a role in the regulation of humoral immunity. Activates NF-kappa-B and JNK.
宿主种属 人(Human)
特异性 CD3E & TNFRSF17
种属反应性 人(Human)
偶联 Unconjugated
作用类型 结合剂
作用机制 T 细胞表面糖蛋白的结合剂 CD3 结合剂

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG4SP
轻链亚型 lambdaC2
SDS-PAGE 143.64 kDa
纯化方法 Protein A purified
储存缓冲液 Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS编号和信息 2119595-80-9
分子类型 抗体

关联靶点(人)

CD3E Tclin 细胞表面糖蛋白 CD3 ε 链(T-cell surface glycoprotein CD3 epsilon chain) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
TNFRSF17 Tclin 肿瘤坏死因子受体超家族成员 17(Tumor necrosis factor receptor superfamily member 17) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

图片

Teclistamab (anti-CD3&BCMA) (Ab175669) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3&BCMA with Teclistamab (anti-CD3&BCMA) (Ab175669) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).

Teclistamab (anti-CD3&BCMA) (Ab175669) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3&BCMA (red) with Teclistamab (anti-CD3&BCMA) (Ab175669) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.

Teclistamab (anti-CD3&BCMA) (Ab175669) - ELISA
Immobilized Recombinant Human CD3 protein (rp175910) at 1.0 μg/mL can bind Teclistamab (anti-CD3&BCMA) (Ab175669) with the EC50 of 99.33 ng/mL.

Teclistamab (anti-CD3&BCMA) (Ab175669) - ELISA
Immobilized Recombinant Human BCMA/TNFRSF17 protein (rp169554) at 1.0 μg/mL can bind Teclistamab (anti-CD3&BCMA) (Ab175669) with the EC50 of 6.582 ng/mL.

Teclistamab (anti-CD3&BCMA) (Ab175669) - SEC
The purity of Teclistamab (anti-CD3&BCMA) (Ab175669) is more than 95% verified by HPLC.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ25F0218080 分析证书 Ab175669
ZJ25F0218079 分析证书 Ab175669
ZJ25F0218078 分析证书 Ab175669

引用文献

1. Pillarisetti K, Powers G, Luistro L, Babich A, Baldwin E, Li Y, Zhang X, Mendonça M, Majewski N, Nanjunda R et al..  (2020)  Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma..  Blood Adv,  (18): (4538-4549).  [PMID:32956453]
2. Moreau P, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, Nooka AK, Martin T, Rosinol L, Chari A et al..  (2022)  Teclistamab in Relapsed or Refractory Multiple Myeloma..  N Engl J Med,  387  (6): (495-505).  [PMID:35661166]
3.  (2022)  Teclistamab Approved for Myeloma..  Cancer Discov,  (OF1).  [PMID:36321843]

溶液计算器